Sona Nanotech Inc C.SONA

Alternate Symbol(s): SNANF

Technology Scientific & Technical Instruments

Sona Nanotech Inc. is a nanotechnology life sciences company that has developed multiple methods for the manufacturing of various types of gold nanoparticles. The Company is engaged in the research and development of its technology for use in multiplex diagnostic testing platforms and biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of CTAB (cetyltrimethylammonium), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company leverages its core proprietary gold nanorod (GNR) manufacturing technology and laboratory assets to focus on the development of diagnostic tests and biologic reagents, and the advancement of its GNR intellectual property.

CSE:SONA - Post by User

Sona Nanotech Inc > REVIEW

<< Previous

Bullboard Posts

Next >>

Comment by Moemoney42on Sep 08, 2020 1:20pm

181 Views

Post# 31520788

RE:RE:RE:REVIEW

LOL... yup there's hope for everyone I suppose.. I'd like to know why you go silent when posters post non truths/BS but the minute somone posts something that's not aligned with the positive stance you're all over them... kind of a double standard wouldn't you say..? You gotta admit there have been MANY posts here claiming things that are NOT TRUE to be fair.

whatdoiknow123 wrote: Moemoney,

I much prefer it when you put your reasonable face on, there´s hope for you yet.

I take your point on possible Saudivax investment in Sona but doubt it. The Saudis invest big and I think any investment they might have made would have been notifiable. It would also almost certainly have had to be declared in some fashion in the Approval submission process.

I do not say that the licensing partnership is likely but it is an intriguing prospect.